Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sarachaga, MJ
   Difficulties in the diagnosis and treatment of acute lower respiratory tract infections in Uruguay
   PEDIATRIC PULMONOLOGY
   
   M.J. Sarachaga, "Difficulties in the diagnosis and treatment of acute lower respiratory tract infections in Uruguay", PEDIAT PULM, 2001, pp. 159-160
2. Risoen, PA; Johnsborg, O; Diep, DB; Hamoen, L; Venema, G; Nes, IF
   Regulation of bacteriocin production in Lactobacillus plantarum depends ona conserved promoter arrangement with consensus binding sequence
   MOLECULAR GENETICS AND GENOMICS
   
   P.A. Risoen et al., "Regulation of bacteriocin production in Lactobacillus plantarum depends ona conserved promoter arrangement with consensus binding sequence", MOL GENET G, 265(1), 2001, pp. 198-206
3. Redfield, RJ
   Do bacteria have sex?
   NATURE REVIEWS GENETICS
   
   R.J. Redfield, "Do bacteria have sex?", NAT REV GEN, 2(8), 2001, pp. 634-639
4. Gurtler, V; Mayall, BC
   Genomic approaches to typing, taxonomy and evolution of bacterial isolates
   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
   
   V. Gurtler e B.C. Mayall, "Genomic approaches to typing, taxonomy and evolution of bacterial isolates", INT J SY EV, 51, 2001, pp. 3-16
5. Kempf, VAJ; Volkmann, B; Schaller, M; Sander, CA; Alitalo, K; Riess, T; Autenrieth, IB
   Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations
   CELLULAR MICROBIOLOGY
   
   V.A.J. Kempf et al., "Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations", CELL MICROB, 3(9), 2001, pp. 623-632
6. Huang, SH; Jang, AY
   Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier
   CELLULAR MICROBIOLOGY
   
   S.H. Huang e A.Y. Jang, "Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier", CELL MICROB, 3(5), 2001, pp. 277-287
7. Mohan, PV; Heath, PT
   Pneumococcal disease in childhood
   HOSPITAL MEDICINE
   
   P.V. Mohan e P.T. Heath, "Pneumococcal disease in childhood", HOSP MED, 62(7), 2001, pp. 406-409
8. Kleineidam, RG; Kruse, S; Roggentin, P; Schauer, R
   Elucidation of the role of functional amino acid residues of the small sialidase from Clostridium perfringens by site-directed mutagenesis
   BIOLOGICAL CHEMISTRY
   
   R.G. Kleineidam et al., "Elucidation of the role of functional amino acid residues of the small sialidase from Clostridium perfringens by site-directed mutagenesis", BIOL CHEM, 382(2), 2001, pp. 313-319
9. Pierce, AB; Hoy, JF
   Is the recommendation for pneumococcal vaccination of HIV patients evidence based?
   JOURNAL OF CLINICAL VIROLOGY
   
   A.B. Pierce e J.F. Hoy, "Is the recommendation for pneumococcal vaccination of HIV patients evidence based?", J CLIN VIRO, 22(3), 2001, pp. 255-261
10. Anderson, VE; Osheroff, N
    Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde
    CURRENT PHARMACEUTICAL DESIGN
    
    V.E. Anderson e N. Osheroff, "Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde", CUR PHARM D, 7(5), 2001, pp. 337-353
11. Markham, PN; Neyfakh, AA
    Efflux-mediated drug resistance in Gram-positive bacteria
    CURRENT OPINION IN MICROBIOLOGY
    
    P.N. Markham e A.A. Neyfakh, "Efflux-mediated drug resistance in Gram-positive bacteria", CURR OPIN M, 4(5), 2001, pp. 509-514
12. Spratt, BG; Hanage, WP; Feil, EJ
    The relative contributions of recombination and point mutation to the diversification of bacterial clones
    CURRENT OPINION IN MICROBIOLOGY
    
    B.G. Spratt et al., "The relative contributions of recombination and point mutation to the diversification of bacterial clones", CURR OPIN M, 4(5), 2001, pp. 602-606
13. Rakkar, S; Roberts, K; Towe, BF; Flores, SM; Heyd, A; Warner, J
    Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    S. Rakkar et al., "Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience", INT J CL PR, 55(5), 2001, pp. 309-315
14. French, G
    Linezolid
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    G. French, "Linezolid", INT J CL PR, 55(1), 2001, pp. 59-63
15. O'Brien, K
    Disease transmission: Routes, contributing factors and herd immunity
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    K. O'Brien, "Disease transmission: Routes, contributing factors and herd immunity", INT J CL PR, 2001, pp. 5-7
16. Clanton, M
    Pneumococcal disease in United States children: Prevalence and treatment
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    M. Clanton, "Pneumococcal disease in United States children: Prevalence and treatment", INT J CL PR, 2001, pp. 13-21
17. Dagan, R
    Conjugate vaccines: Potential impact on antibiotic use?
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    R. Dagan, "Conjugate vaccines: Potential impact on antibiotic use?", INT J CL PR, 2001, pp. 27-28
18. Chan, MS; Maiden, MCJ; Spratt, BG
    Database-driven multi locus sequence typing (MLST) of bacterial pathogens
    BIOINFORMATICS
    
    M.S. Chan et al., "Database-driven multi locus sequence typing (MLST) of bacterial pathogens", BIOINFORMAT, 17(11), 2001, pp. 1077-1083
19. Moore, JE; Millar, BC; Yongmin, X; Woodford, N; Vincent, S; Goldsmith, CE; McClurg, RB; Crowe, M; Hone, R; Murphy, PG
    A rapid molecular assay for the detection of antibiotic resistance determinants in causal agents of infective endocarditis
    JOURNAL OF APPLIED MICROBIOLOGY
    
    J.E. Moore et al., "A rapid molecular assay for the detection of antibiotic resistance determinants in causal agents of infective endocarditis", J APPL MICR, 90(5), 2001, pp. 719-726
20. Dougherty, TJ; Beaulieu, D; Barrett, JF
    New quinolones and the impact on resistance
    DRUG DISCOVERY TODAY
    
    T.J. Dougherty et al., "New quinolones and the impact on resistance", DRUG DISC T, 6(10), 2001, pp. 529-536
21. Bonfiglio, G; Furneri, PM
    Novel streptogramin antibiotics
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    G. Bonfiglio e P.M. Furneri, "Novel streptogramin antibiotics", EXPERT OP I, 10(2), 2001, pp. 185-198
22. Blondeau, JM
    Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    J.M. Blondeau, "Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections", EXPERT OP I, 10(2), 2001, pp. 213-237
23. Dougherty, TJ; Barrett, JF
    ABT-773: a new ketolide antibiotic
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    T.J. Dougherty e J.F. Barrett, "ABT-773: a new ketolide antibiotic", EXPERT OP I, 10(2), 2001, pp. 343-351
24. Yassin, HM; Dever, LL
    Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    H.M. Yassin e L.L. Dever, "Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections", EXPERT OP I, 10(2), 2001, pp. 353-367
25. Jakubovics, NS; Jenkinson, HF
    Out of the iron age: new insights into the critical role of manganese homeostasis in bacteria
    MICROBIOLOGY-SGM
    
    N.S. Jakubovics e H.F. Jenkinson, "Out of the iron age: new insights into the critical role of manganese homeostasis in bacteria", MICROBI-SGM, 147, 2001, pp. 1709-1718
26. Lindsay, JA; Foster, SJ
    zur: a Zn2+-responsive regulatory element of Staphylococcus aureus
    MICROBIOLOGY-SGM
    
    J.A. Lindsay e S.J. Foster, "zur: a Zn2+-responsive regulatory element of Staphylococcus aureus", MICROBI-SGM, 147, 2001, pp. 1259-1266
27. Foussard, M; Cabantous, S; Pedelacq, JD; Guillet, V; Tranier, S; Mourey, L; Birck, C; Samama, JP
    The molecular puzzle of two-component signaling cascades
    MICROBES AND INFECTION
    
    M. Foussard et al., "The molecular puzzle of two-component signaling cascades", MICROBES IN, 3(5), 2001, pp. 417-424
28. Mouton, JW; Jansz, AR
    The DUEL study: a multi-center in vitro, evaluation of linezolid compared with other antibiotics in the Netherlands
    CLINICAL MICROBIOLOGY AND INFECTION
    
    J.W. Mouton e A.R. Jansz, "The DUEL study: a multi-center in vitro, evaluation of linezolid compared with other antibiotics in the Netherlands", CL MICRO IN, 7(9), 2001, pp. 486-491
29. Gonullu, N; Aktas, Z; Salcioglu, M; Bal, C; Ang, O
    Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates
    CLINICAL MICROBIOLOGY AND INFECTION
    
    N. Gonullu et al., "Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates", CL MICRO IN, 7(9), 2001, pp. 499-503
30. Pantosti, A; D'Ambrosio, F; Bordi, E; d'Abusco, AS; Del Grosso, M
    Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy
    CLINICAL MICROBIOLOGY AND INFECTION
    
    A. Pantosti et al., "Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy", CL MICRO IN, 7(9), 2001, pp. 503-506
31. Campos, J
    Haemophilus influenzae: from the post-vaccination era to antibiotic resistance
    CLINICAL MICROBIOLOGY AND INFECTION
    
    J. Campos, "Haemophilus influenzae: from the post-vaccination era to antibiotic resistance", CL MICRO IN, 7(6), 2001, pp. 287-290
32. Bax, R; Bywater, R; Cornaglia, G; Goossens, H; Hunter, P; Isham, V; Jarlier, V; Jones, R; Phillips, I; Sahm, D; Senn, S; Struelens, M; Taylor, D; White, A
    Surveillance of antimicrobial resistance - what, how and whither?
    CLINICAL MICROBIOLOGY AND INFECTION
    
    R. Bax et al., "Surveillance of antimicrobial resistance - what, how and whither?", CL MICRO IN, 7(6), 2001, pp. 316-325
33. Kragsbjerg, P; Fredlund, H
    The effects of live Streptococcus pneumoniae and tumor necrosis factor-alpha on neutrophil oxidative burst and beta 2-integrin expression
    CLINICAL MICROBIOLOGY AND INFECTION
    
    P. Kragsbjerg e H. Fredlund, "The effects of live Streptococcus pneumoniae and tumor necrosis factor-alpha on neutrophil oxidative burst and beta 2-integrin expression", CL MICRO IN, 7(3), 2001, pp. 125-129
34. Jacobs, MR
    Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters
    CLINICAL MICROBIOLOGY AND INFECTION
    
    M.R. Jacobs, "Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters", CL MICRO IN, 7(11), 2001, pp. 589-596
35. Esel, D; Sumerkan, B; Kocagoz, S
    Epidemiology of penicillin resistance in Streptococcus pneumoniae isolatesin Kayseri, Turkey
    CLINICAL MICROBIOLOGY AND INFECTION
    
    D. Esel et al., "Epidemiology of penicillin resistance in Streptococcus pneumoniae isolatesin Kayseri, Turkey", CL MICRO IN, 7(10), 2001, pp. 548-552
36. Paradisi, F; Corti, G; Cinelli, R
    Streptococcus pneumoniae as an agent of nosocomial infection: treatment inthe era of penicillin-resistant strains
    CLINICAL MICROBIOLOGY AND INFECTION
    
    F. Paradisi et al., "Streptococcus pneumoniae as an agent of nosocomial infection: treatment inthe era of penicillin-resistant strains", CL MICRO IN, 7, 2001, pp. 34-42
37. Carbon, C
    Ketolides: An innovative solution to an evolving world of respiratory pathogens - Proceedings of a Symposium held at the 10th European Congress of Clinical Microbiology and Infectious Diseases - Stockholm, Sweden, 30 May 2000 - Introduction
    CLINICAL MICROBIOLOGY AND INFECTION
    
    C. Carbon, "Ketolides: An innovative solution to an evolving world of respiratory pathogens - Proceedings of a Symposium held at the 10th European Congress of Clinical Microbiology and Infectious Diseases - Stockholm, Sweden, 30 May 2000 - Introduction", CL MICRO IN, 7, 2001, pp. 1-1
38. Felmingham, D
    Microbiological profile of telithromycin, thee first ketolide antimicrobial
    CLINICAL MICROBIOLOGY AND INFECTION
    
    D. Felmingham, "Microbiological profile of telithromycin, thee first ketolide antimicrobial", CL MICRO IN, 7, 2001, pp. 2-10
39. Leclercq, R
    Safeguarding future antimicrobial options: strategies to minimize resistance
    CLINICAL MICROBIOLOGY AND INFECTION
    
    R. Leclercq, "Safeguarding future antimicrobial options: strategies to minimize resistance", CL MICRO IN, 7, 2001, pp. 18-23
40. Drusano, G
    Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin
    CLINICAL MICROBIOLOGY AND INFECTION
    
    G. Drusano, "Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin", CL MICRO IN, 7, 2001, pp. 24-29
41. Finch, R
    Community-acquired pneumonia: the evolving challenge
    CLINICAL MICROBIOLOGY AND INFECTION
    
    R. Finch, "Community-acquired pneumonia: the evolving challenge", CL MICRO IN, 7, 2001, pp. 30-38
42. Koornhof, HJ; Keddy, K; McGee, L
    Clonal expansion of bacterial pathogens across the world
    JOURNAL OF TRAVEL MEDICINE
    
    H.J. Koornhof et al., "Clonal expansion of bacterial pathogens across the world", J TRAVEL M, 8(1), 2001, pp. 29-40
43. Perry, CM; Goa, KL
    Community-acquired pneumonia and its management - The role of levofloxacin
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    C.M. Perry e K.L. Goa, "Community-acquired pneumonia and its management - The role of levofloxacin", DIS MANAG H, 9(1), 2001, pp. 43-64
44. Rubins, JB; Janoff, EN
    Pneumococcal disease in the elderly - What is preventing vaccine efficacy?
    DRUGS & AGING
    
    J.B. Rubins e E.N. Janoff, "Pneumococcal disease in the elderly - What is preventing vaccine efficacy?", DRUG AGING, 18(5), 2001, pp. 305-311
45. Obaji, A; Sethi, S
    Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?
    DRUGS & AGING
    
    A. Obaji e S. Sethi, "Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?", DRUG AGING, 18(1), 2001, pp. 1-11
46. Arias, RB; Lopez, MG; Sanchez, AP
    Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae
    JOURNAL OF CHEMOTHERAPY
    
    R.B. Arias et al., "Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae", J CHEMOTHER, 13(5), 2001, pp. 535-540
47. Gur, D; Guciz, B; Hascelik, G; Esel, D; Sumerkan, B; Over, U; Soyletir, G; Ongen, B; Kaygusuz, A; Toreci, K
    Streptococcus pneumoniae penicillin resistance in Turkey
    JOURNAL OF CHEMOTHERAPY
    
    D. Gur et al., "Streptococcus pneumoniae penicillin resistance in Turkey", J CHEMOTHER, 13(5), 2001, pp. 541-545
48. Bantar, C; Nicola, F; Canigia, LF; Arenoso, HJ; Soutric, J; Montoto, M; Blanco, M; Smayevsky, J; Jasovich, A
    Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms
    JOURNAL OF CHEMOTHERAPY
    
    C. Bantar et al., "Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms", J CHEMOTHER, 13(4), 2001, pp. 402-406
49. Ball, P; Wilson, R; Mandell, L; Brown, J; Henkel, T
    Efficacy of gemifloxacin in acute exacerbations of chromic bronchitis: a randomised, double-blind comparison with trovafloxacin
    JOURNAL OF CHEMOTHERAPY
    
    P. Ball et al., "Efficacy of gemifloxacin in acute exacerbations of chromic bronchitis: a randomised, double-blind comparison with trovafloxacin", J CHEMOTHER, 13(3), 2001, pp. 288-298
50. Perez-Trallero, E; Alkorta, M; Gimenez, MJ; Vicente, D; Aguilar, L
    Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin
    JOURNAL OF CHEMOTHERAPY
    
    E. Perez-Trallero et al., "Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin", J CHEMOTHER, 13(2), 2001, pp. 118-125
51. Eltahawy, ATAE
    Antimicrobial resistance of Streptococcus pneumoniae at a university hospital in Saudi Arabia
    JOURNAL OF CHEMOTHERAPY
    
    A.T.A.E. Eltahawy, "Antimicrobial resistance of Streptococcus pneumoniae at a university hospital in Saudi Arabia", J CHEMOTHER, 13(2), 2001, pp. 148-153
52. Mokaddas, EM; Wilson, S; Sanyal, SC
    Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait
    JOURNAL OF CHEMOTHERAPY
    
    E.M. Mokaddas et al., "Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait", J CHEMOTHER, 13(2), 2001, pp. 154-160
53. McCullers, JA; Tuomanen, EI
    Molecular pathogenesis of pneumococcal pneumonia
    FRONTIERS IN BIOSCIENCE
    
    J.A. McCullers e E.I. Tuomanen, "Molecular pathogenesis of pneumococcal pneumonia", FRONT BIOSC, 6, 2001, pp. D877-D889
54. Jedrzejas, MJ
    Pneumococcal virulence factors: Structure and function
    MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    
    M.J. Jedrzejas, "Pneumococcal virulence factors: Structure and function", MICRO M B R, 65(2), 2001, pp. 187
55. Chopra, I; Roberts, M
    Tetracycline antibiotics: Mode of action, applications, molecular biology,and epidemiology of bacterial resistance
    MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    
    I. Chopra e M. Roberts, "Tetracycline antibiotics: Mode of action, applications, molecular biology,and epidemiology of bacterial resistance", MICRO M B R, 65(2), 2001, pp. 232
56. Gmuender, H; Kuratli, K; Di Padova, K; Gray, CP; Keck, W; Evers, S
    Gene expression changes triggered by exposure of Haemophilus influenzae tonovobiocin or ciprofloxacin: Combined transcription and translation analysis
    GENOME RESEARCH
    
    H. Gmuender et al., "Gene expression changes triggered by exposure of Haemophilus influenzae tonovobiocin or ciprofloxacin: Combined transcription and translation analysis", GENOME RES, 11(1), 2001, pp. 28-42
57. Palavecino, EL
    The crisis of resistant pathogens in respiratory tract infections - Use ofpharmacodynamic principles
    AMERICAN JOURNAL OF MANAGED CARE
    
    E.L. Palavecino, "The crisis of resistant pathogens in respiratory tract infections - Use ofpharmacodynamic principles", AM J M CARE, 7(6), 2001, pp. S170-S177
58. Poole, MD
    Appropriate antibiotic use in treating respiratory tract infections
    AMERICAN JOURNAL OF MANAGED CARE
    
    M.D. Poole, "Appropriate antibiotic use in treating respiratory tract infections", AM J M CARE, 7(6), 2001, pp. S178-S182
59. Avigan, D; Pirofski, L; Lazarus, HM
    Vaccination against infectious disease following hematopoietic stem cell transplantation
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    D. Avigan et al., "Vaccination against infectious disease following hematopoietic stem cell transplantation", BIOL BLOOD, 7(3), 2001, pp. 171-183
60. McCarty, JM; Pierce, PF
    Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    
    J.M. McCarty e P.F. Pierce, "Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis", ANN ALLER A, 87(4), 2001, pp. 327-334
61. Hooper, DC
    Emerging mechanisms of fluoroquinolone resistance
    EMERGING INFECTIOUS DISEASES
    
    D.C. Hooper, "Emerging mechanisms of fluoroquinolone resistance", EM INFECT D, 7(2), 2001, pp. 337-341
62. Culley, CM; Lacy, MK; Klutman, N; Edwards, B
    Moxifloxacin: Clinical efficacy and safety
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    C.M. Culley et al., "Moxifloxacin: Clinical efficacy and safety", AM J HEAL S, 58(5), 2001, pp. 379-388
63. de las Rivas, B; Garcia, JL; Lopez, R; Garcia, P
    Molecular characterization of the pneumococcal teichoic acid phosphorylcholine esterase
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    
    B. de las Rivas et al., "Molecular characterization of the pneumococcal teichoic acid phosphorylcholine esterase", MICROB DR R, 7(3), 2001, pp. 213-222
64. Gravesen, A; Sorensen, K; Aarestrup, FM; Knochel, S
    Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    
    A. Gravesen et al., "Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics", MICROB DR R, 7(2), 2001, pp. 127-135
65. Baddour, VT; Hugenberg, ST; Brandt, KD; Yang, EL
    Pneumococcal pyomyositis: A patient with diagnostic problems and complications
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    
    V.T. Baddour et al., "Pneumococcal pyomyositis: A patient with diagnostic problems and complications", JCR-J CLIN, 7(1), 2001, pp. 21-29
66. Niederman, MS; Mandell, LA; Anzueto, A; Bass, JB; Broughton, WA; Campbell, GD; Dean, N; File, T; Fine, MJ; Gross, PA; Martinez, F; Marrie, TJ; Plouffe, JF; Ramirez, J; Sarosi, GA; Torres, A; Wilson, R; Yu, VL
    Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    M.S. Niederman et al., "Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention", AM J R CRIT, 163(7), 2001, pp. 1730-1754
67. Sullivan, JH; Mitchell, TJ; Steinhoff, MC
    Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    J.H. Sullivan et al., "Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia", AM J R CRIT, 163(3), 2001, pp. 680-684
68. Bilwes, AM; Quezada, CM; Croal, LR; Crane, BR; Simon, MI
    Nucleotide binding by the histidine kinase CheA
    NATURE STRUCTURAL BIOLOGY
    
    A.M. Bilwes et al., "Nucleotide binding by the histidine kinase CheA", NAT ST BIOL, 8(4), 2001, pp. 353-360
69. Fernandez-Tornero, C; Lopez, R; Garcia, E; Gimenez-Gallego, G; Romero, A
    A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA
    NATURE STRUCTURAL BIOLOGY
    
    C. Fernandez-Tornero et al., "A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA", NAT ST BIOL, 8(12), 2001, pp. 1020-1024
70. Mangione-Smith, R; McGlynn, EA; Elliott, MN; McDonald, L; Franz, CE; Kravitz, RL
    Parent expectations for antibiotics, physician-parent communication, and satisfaction
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    
    R. Mangione-Smith et al., "Parent expectations for antibiotics, physician-parent communication, and satisfaction", ARCH PED AD, 155(7), 2001, pp. 800-806
71. Freedman, SB; Marrocco, A; Pirie, J; Dick, PT
    Predictors of bacterial meningitis in the era after Haemophilus influenzae
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    
    S.B. Freedman et al., "Predictors of bacterial meningitis in the era after Haemophilus influenzae", ARCH PED AD, 155(12), 2001, pp. 1301-1306
72. Romero-Steiner, S; Fernandez, J; Biltoft, C; Wohl, ME; Sanchez, J; Feris, J; Balter, S; Levine, OS; Carlone, GM
    Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate)
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    S. Romero-Steiner et al., "Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate)", CL DIAG LAB, 8(6), 2001, pp. 1115-1119
73. Leiva, LE; Butler, B; Hempe, J; Ortigas, AP; Sorensen, RU
    Up-regulation of CD40 ligand and induction of a TH2 response in children immunized with pneumococcal polysaccharide vaccines
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    L.E. Leiva et al., "Up-regulation of CD40 ligand and induction of a TH2 response in children immunized with pneumococcal polysaccharide vaccines", CL DIAG LAB, 8(2), 2001, pp. 233-240
74. Jansen, WTM; Vakevainen-Anttila, M; Kayhty, H; Nahm, M; Bakker, N; Verhoef, J; Snippe, H; Verheul, AFM
    Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated witha pneumococcal conjugate vaccine
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    W.T.M. Jansen et al., "Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated witha pneumococcal conjugate vaccine", CL DIAG LAB, 8(2), 2001, pp. 245-250
75. Concepcion, NF; Frasch, CE
    Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    N.F. Concepcion e C.E. Frasch, "Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay", CL DIAG LAB, 8(2), 2001, pp. 266-272
76. Vakevainen, M; Jansen, W; Saeland, E; Jonsdottir, I; Snippe, H; Verheul, A; Kayhty, H
    Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    M. Vakevainen et al., "Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?", CL DIAG LAB, 8(2), 2001, pp. 363-369
77. Lawrence, JG
    Catalyzing bacterial speciation: Correlating lateral transfer with geneticheadroom
    SYSTEMATIC BIOLOGY
    
    J.G. Lawrence, "Catalyzing bacterial speciation: Correlating lateral transfer with geneticheadroom", SYST BIOL, 50(4), 2001, pp. 479-496
78. Empey, PE; Jennings, HR; Thornton, AC; Rapp, RP; Evans, ME
    Levofloxacin failure in a patient with pneumococcal pneumonia
    ANNALS OF PHARMACOTHERAPY
    
    P.E. Empey et al., "Levofloxacin failure in a patient with pneumococcal pneumonia", ANN PHARMAC, 35(6), 2001, pp. 687-690
79. Bain, KT; Wittbrodt, ET
    Linezolid for the treatment of resistant gram-positive cocci
    ANNALS OF PHARMACOTHERAPY
    
    K.T. Bain e E.T. Wittbrodt, "Linezolid for the treatment of resistant gram-positive cocci", ANN PHARMAC, 35(5), 2001, pp. 566-575
80. Amsden, GW; Amankwa, K
    Pneumococcal resistance: The treatment challenge
    ANNALS OF PHARMACOTHERAPY
    
    G.W. Amsden e K. Amankwa, "Pneumococcal resistance: The treatment challenge", ANN PHARMAC, 35(4), 2001, pp. 480-488
81. Gonzales, R; Malone, DC; Maselli, JH; Sande, MA
    Excessive antibiotic use for acute respiratory infections in the United States
    CLINICAL INFECTIOUS DISEASES
    
    R. Gonzales et al., "Excessive antibiotic use for acute respiratory infections in the United States", CLIN INF D, 33(6), 2001, pp. 757-762
82. Moroney, JF; Fiore, AE; Harrison, LH; Patterson, JE; Farley, MM; Jorgensen, JH; Phelan, M; Facklam, RR; Cetron, MS; Breiman, RF; Kolczak, M; Schuchat, A
    Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    CLINICAL INFECTIOUS DISEASES
    
    J.F. Moroney et al., "Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance", CLIN INF D, 33(6), 2001, pp. 797-805
83. Karstaedt, AS; Khoosal, M; Crewe-Brown, HH
    Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade
    CLINICAL INFECTIOUS DISEASES
    
    A.S. Karstaedt et al., "Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade", CLIN INF D, 33(5), 2001, pp. 610-614
84. Le, TP; Miller, LG
    Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: A decision and cost analysis
    CLINICAL INFECTIOUS DISEASES
    
    T.P. Le e L.G. Miller, "Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: A decision and cost analysis", CLIN INF D, 33(5), 2001, pp. 615-621
85. Whitney, CG; Schaffner, W; Butler, JC
    Rethinking recommendations for use of pneumococcal vaccines in adults
    CLINICAL INFECTIOUS DISEASES
    
    C.G. Whitney et al., "Rethinking recommendations for use of pneumococcal vaccines in adults", CLIN INF D, 33(5), 2001, pp. 662-675
86. Fraser, D; Givon-Lavi, N; Bilenko, N; Dagan, R
    A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: Implications for vaccine choice
    CLINICAL INFECTIOUS DISEASES
    
    D. Fraser et al., "A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: Implications for vaccine choice", CLIN INF D, 33(4), 2001, pp. 421-427
87. Borer, A; Meirson, H; Peled, N; Porat, N; Dagan, R; Fraser, D; Gilad, J; Zehavi, N; Yagupsky, P
    Antibiotic-resistant pneumococci carried by young children do not appear to disseminate to adult members of a closed community
    CLINICAL INFECTIOUS DISEASES
    
    A. Borer et al., "Antibiotic-resistant pneumococci carried by young children do not appear to disseminate to adult members of a closed community", CLIN INF D, 33(4), 2001, pp. 436-444
88. Klugman, KP
    Antibiotic selection of multiply resistant pneumococci
    CLINICAL INFECTIOUS DISEASES
    
    K.P. Klugman, "Antibiotic selection of multiply resistant pneumococci", CLIN INF D, 33(4), 2001, pp. 489-491
89. Okeke, IN; Edelman, R
    Dissemination of antibiotic-resistant bacteria across geographic borders
    CLINICAL INFECTIOUS DISEASES
    
    I.N. Okeke e R. Edelman, "Dissemination of antibiotic-resistant bacteria across geographic borders", CLIN INF D, 33(3), 2001, pp. 364-369
90. Drusano, GL; Preston, SL; Owens, RC; Ambrose, PG
    Fluoroquinolone pharmacodynamics
    CLINICAL INFECTIOUS DISEASES
    
    G.L. Drusano et al., "Fluoroquinolone pharmacodynamics", CLIN INF D, 33(12), 2001, pp. 2091-2092
91. Schentag, JJ; Gilliland, KK; Paladino, JA
    Fluoroquinolone pharmacodynamics - Reply
    CLINICAL INFECTIOUS DISEASES
    
    J.J. Schentag et al., "Fluoroquinolone pharmacodynamics - Reply", CLIN INF D, 33(12), 2001, pp. 2092-2096
92. Schutze, GE; Mason, EO; Wald, ER; Barson, WJ; Bradley, JS; Tan, TQ; Kim, KS; Givner, LB; Yogev, R; Kaplan, SL
    Pneumococcal infections in children after transplantation
    CLINICAL INFECTIOUS DISEASES
    
    G.E. Schutze et al., "Pneumococcal infections in children after transplantation", CLIN INF D, 33(1), 2001, pp. 16-21
93. Contopoulos-Ioannidis, DG; Koliofoti, ID; Koutroumpa, IC; Giannakakis, IA; Ioannidis, JPA
    Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: Arandomized trial
    CLINICAL INFECTIOUS DISEASES
    
    D.G. Contopoulos-Ioannidis et al., "Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: Arandomized trial", CLIN INF D, 33(1), 2001, pp. 76-82
94. Kayhty, H; Ahman, H
    Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines
    CLINICAL INFECTIOUS DISEASES
    
    H. Kayhty e H. Ahman, "Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines", CLIN INF D, 33, 2001, pp. S292-S298
95. Tenover, FC
    Development and spread of bacterial resistance to antimicrobial agents: Anoverview
    CLINICAL INFECTIOUS DISEASES
    
    F.C. Tenover, "Development and spread of bacterial resistance to antimicrobial agents: Anoverview", CLIN INF D, 33, 2001, pp. S108-S115
96. Courvalin, P; Trieu-Cuot, P
    Minimizing potential resistance: The molecular view
    CLINICAL INFECTIOUS DISEASES
    
    P. Courvalin e P. Trieu-Cuot, "Minimizing potential resistance: The molecular view", CLIN INF D, 33, 2001, pp. S138-S146
97. Zhao, XL; Drlica, K
    Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies
    CLINICAL INFECTIOUS DISEASES
    
    X.L. Zhao e K. Drlica, "Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies", CLIN INF D, 33, 2001, pp. S147-S156
98. Hooper, DC
    Minimizing potential resistance: The molecular view - A comment on Courvalin and Trieu-Cuot
    CLINICAL INFECTIOUS DISEASES
    
    D.C. Hooper, "Minimizing potential resistance: The molecular view - A comment on Courvalin and Trieu-Cuot", CLIN INF D, 33, 2001, pp. S157-S160
99. Levin, BR
    Minimizing potential resistance: A population dynamics view
    CLINICAL INFECTIOUS DISEASES
    
    B.R. Levin, "Minimizing potential resistance: A population dynamics view", CLIN INF D, 33, 2001, pp. S161-S169
100. Kristinsson, KG
     Mathematical models as tools for evaluating the effectiveness of interventions: A comment on Levin
     CLINICAL INFECTIOUS DISEASES
     
     K.G. Kristinsson, "Mathematical models as tools for evaluating the effectiveness of interventions: A comment on Levin", CLIN INF D, 33, 2001, pp. S174-S179